Non-deductible expenses Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount Target amount of share-based compensation awards (in shares) Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Trade Accounts Receivable Trade Accounts Receivable [Member] Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Amounts settled Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Proceeds from sales and maturities of investments Proceeds from Sale and Maturity of Marketable Securities Senior notes maturing due 2022 Senior Notes Maturing Due 2022 [Member] Senior Notes Maturing Due 2022 [Member] Euro Deferred Shares Euro Deferred Shares [Member] Euro Deferred Shares [Member] U.S. tax reform impact Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Research, Development, and Computer Software Research, Development, and Computer Software, Policy [Policy Text Block] Award adjustment rate Share-based Compensation, Award Adjustment Rate Share-based Compensation, Award Adjustment Rate Licensing Licensing Agreements [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] LIABILITIES AND SHAREHOLDERS' DEFICIT Liabilities and Equity [Abstract] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Assets and liabilities, lessee Assets And Liabilities, Lessee [Table Text Block] Assets And Liabilities, Lessee [Table Text Block] Endo 401(k) Plan Endo 401(k) Plan [Member] Endo 401(k) Plan [Member] PSP LLC PSP LLC [Member] PSP LLC Security Exchange Name Security Exchange Name Acquisition-related contingent consideration—noncurrent Acquisition Related Contingent Consideration Long Term [Member] Acquisition-Related Contingent Consideration-Long Term [Member] Total current liabilities Liabilities, Current Accounts Receivable Accounts Receivable [Policy Text Block] Vested employee options and benefits Asset Acquisition, Consideration Transferred, Employee Benefits And Share-Based Compensation Asset Acquisition, Consideration Transferred, Employee Benefits And Share-Based Compensation Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Restricted and performance stock units, weighted average grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Restricted Cash and Cash Equivalents Items [Line Items] Restricted Cash and Cash Equivalents Items [Line Items] Variable Rate [Domain] Variable Rate [Domain] January 2018 restructuring initiative January 2018 Restructuring [Member] January 2018 Restructuring [Member] Total future lease payments Finance Lease, Liability, Payment, Due ASSETS Assets: Assets [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Restricted Cash and Cash Equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Compensation related to share-based awards Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Operating cash payments for operating leases Operating Lease, Payments OTHER COMPREHENSIVE (LOSS) INCOME Comprehensive Income (Loss) Note [Text Block] 2023 Long-Term Debt, Maturity, Year Three ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Vested and expected to vest, end of period (in shares) Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Entity Address, Country Entity Address, Country Additional 7.5% Senior Secured Notes Due 2027 Additional Seven Point Five Percent Senior Secured Notes Due Twenty Twenty Seven [Member] Additional Seven Point Five Percent Senior Secured Notes Due Twenty Twenty Seven Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Treasury stock, shares, acquired (in shares) Treasury Stock, Shares, Acquired 2021 Lessee, Operating Lease, Liability, to be Paid, Year One Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 2024 Lessee, Operating Lease, Liability, to be Paid, Year Four Financial assets and liabilities measured at fair value on recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Discontinued operations, disposed of by means other than sale, abandonment Discontinued Operations, Disposed of by Means Other than Sale, Abandonment [Member] Accelerated depreciation charges Restructuring and Related Cost, Accelerated Depreciation Employee separation, continuity and other benefit-related costs Employee Separation, Continuity, and Other Benefit Related Costs [Member] Employee Separation, Continuity, and Other Benefit Related Costs [Member] U.S. State Current State and Local Tax Expense (Benefit) Sterile Injectables Branded Sterile Injectables [Member] Branded Sterile Injectables [Member] Product line revenue reporting threshold Product Line Revenue Reporting Threshold Product Line Revenue Reporting Threshold Exercise price range, lower range limit (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit Impairments Impairment of Intangible Assets, Finite-lived, Effect On Accumulated Amortization Impairment of Intangible Assets, Finite-lived, Effect On Accumulated Amortization Continuing operations (in dollars per share) Continuing operations, diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Certain property, plant and equipment Tangible Asset Impairment Charges Discontinued operations (in dollars per share) Discontinued operations, diluted (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share Building Building [Member] OTHER COMPREHENSIVE INCOME (LOSS): Other Comprehensive Income (Loss), Net of Tax [Abstract] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Base purchase price Payments For Asset Acquisitions Payments For Asset Acquisitions OTHER LIABILITIES Other Liabilities, Noncurrent DEFERRED INCOME TAXES Deferred Income Tax Assets, Net Financing cash payments for finance leases Finance Lease, Principal Payments Work-in-process Inventory, Work in Process, Net of Reserves Valuation Allowance for Deferred Tax Assets SEC Schedule, 12-09, Valuation Allowance, Deferred Tax Asset [Member] Effect of foreign exchange rate Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Corporate unallocated costs Segment reconciling items Segment Reconciling Items [Member] Inventories, net Total Inventory, Net 6.00% Senior Notes due 2023 Six Point Zero Percent Senior Notes Due Two Thousand Twenty Three [Member] Six Point Zero Percent Senior Notes Due Two Thousand Twenty Three [Member] Measurement Frequency [Domain] Measurement Frequency [Domain] XIAFLEX and QWO XIAFLEX And QWO [Member] XIAFLEX And QWO Cash paid into Qualified Settlement Funds for mesh legal settlements Settlement Funds, Additions Settlement Funds, Additions Tranche Three Share-based Payment Arrangement, Tranche Three [Member] Jubilant Hollister Stier Laboratories L L C Jubilant Hollister Stier Laboratories L L C [Member] Jubilant Hollister Stier Laboratories L L C Concentration risk, percentage Concentration Risk, Percentage Expiration period Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items] Statement [Line Items] Statement [Line Items] Measurement Input Type [Domain] Measurement Input Type [Domain] APLISOL® Aplisol [Member] Aplisol [Member] Statement [Table] Statement [Table] Restructuring and related costs, expected cost savings Restructuring And Related Costs, Expected Cost Savings Restructuring And Related Costs, Expected Cost Savings Type of Restructuring [Domain] Type of Restructuring [Domain] Statistical Measurement [Axis] Statistical Measurement [Axis] Certain legal costs Legal Fees Deferred income taxes Deferred Income Taxes and Tax Credits Accrued expenses and customer allowances Deferred Tax Assets, Tax Deferred Expense India INDIA Fair value, measurements, nonrecurring Fair Value, Nonrecurring [Member] Weighted average Weighted Average [Member] Employee separation, retention, and other benefit related costs Employee Separation, Retention, and Other Benefit Related Costs [Member] Employee Separation, Retention, and Other Benefit Related Costs [Member] Schedule of Asset Acquisition Schedule Of Asset Acquisition [Table Text Block] Schedule Of Asset Acquisition Contract with Customer, Asset and Liability [Abstract] Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract] Entity Small Business Entity Small Business Longterm purchase commitment purchased amount LongtermPurchaseCommitmentPurchasedAmount LongtermPurchaseCommitmentPurchasedAmount Consolidation and basis of presentation Consolidation, Policy [Policy Text Block] VASOSTRICT and/or ADRENALIN VASOSTRICT and/or ADRENALIN [Member] VASOSTRICT and/or ADRENALIN [Member] DEBT Debt Disclosure [Text Block] Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Cost of revenues Cost of Revenue Share Repurchase Program [Domain] Share Repurchase Program [Domain] Other Indefinite-lived Intangible Assets, Other Indefinite-lived Intangible Assets, Other Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Amendment Flag Amendment Flag Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Restricted Stock Units And Performance Stock Units [Member] Restricted Stock Units And Performance Stock Units [Member] WEIGHTED AVERAGE SHARES: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Accrued interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Beginning of period End of period Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Changes in Fair Value Recorded in Earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments And Accretion Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Adjustments And Accretion Deferred tax assets: Deferred Tax Assets, Gross [Abstract] Corporate unallocated Corporate, Non-Segment [Member] Number of shares available for grant (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Other Other Accrued Liabilities, Current Other Intangible Assets, Other Intangible Assets, Other Reclassification from AOCI Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent RESTRUCTURING Restructuring and Related Activities Disclosure [Text Block] Measurement Frequency [Axis] Measurement Frequency [Axis] Current portion of legal settlement accrual Loss Contingency, Accrual, Current Financial Instruments [Domain] Financial Instruments [Domain] As of June 30, 2020 Debt Instrument, Redemption, Period Three [Member] 5.75% Senior Notes due 2022 Five Point Seven Five Senior Notes Due On Two Thousand Twenty Two [Member] Five Point Seven Five Senior Notes Due On Two Thousand Twenty Two [Member] In Process Research and Development Assets In Process Research and Development, Policy [Policy Text Block] 7.50% Senior Secured Notes due 2027 Seven Point Five Percent Senior Secured Notes Due Twenty Twenty Seven [Member] Seven Point Five Percent Senior Secured Notes Due Twenty Twenty Seven [Member] Lessee. operating lease, renewal term Lessee, Operating Lease, Renewal Term Commitments and Contingencies Commitments and Contingencies, Policy [Policy Text Block] Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Balance at Beginning of Period Balance at End of Period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Income Statement Location [Domain] Income Statement Location [Domain] 2022 Lessee, Operating Lease, Liability, to be Paid, Year Two State State and Local Jurisdiction State and Local Jurisdiction [Member] Intercompany notes Deferred Tax Liability, Intercompany Notes Deferred Tax Liability, Intercompany Notes Number of shares issued as a part of asset acquisition (in shares) Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Shares Asset Acquisition, Equity Interest Issued Or Issuable, Number Of Shares FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Selling, general and administrative Selling, General and Administrative Expense Lease, cost Lease, Cost [Table Text Block] 2023 Lessee, Operating Lease, Liability, to be Paid, Year Three OTHER ASSETS Other Assets, Noncurrent Plan Name [Axis] Plan Name [Axis] INCOME (LOSS) FROM CONTINUING OPERATIONS Income (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent TOTAL ASSETS Assets Continuity and separation benefits and other cost reduction initiatives Cost Reduction Initiatives Cost Reduction Initiatives Impairments Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Loss contingency accrual, period increase (decrease) Additional charges Loss Contingency Accrual, Provision Unvested awards outstanding (in shares) Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Reporting Unit [Domain] Reporting Unit [Domain] Finance Leases Finance Lease, Liability, Payment, Due [Abstract] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Performance obligation satisfaction period Contract With Customer, Performance Obligation Satisfaction Period Contract With Customer, Performance Obligation Satisfaction Period Cost of revenues Cost of Sales [Member] Finite-Lived Intangible Assets, Developed Technology and License Rights Intangible Assets, Finite-Lived, Policy [Policy Text Block] Concentration of Credit Risk and Credit Losses Concentration Risk, Credit Risk, Policy [Policy Text Block] Number of employees Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options, Number of Employees Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options, Number of Employees Land and buildings Land and Building [Member] Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Level 1 Inputs Fair Value, Inputs, Level 1 [Member] Inventories Increase (Decrease) in Inventories License And Collaboration Agreements [Line Items] License And Collaboration Agreements [Line Items] License And Collaboration Agreements [Line Items] Restricted cash and cash equivalents, noncurrent Restricted Cash and Cash Equivalents, Noncurrent Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Increase (decrease) in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Interest expense, net Interest Income (Expense), Net Additional Paid-in Capital Additional Paid-in Capital [Member] Deferred interest expense Deferred Tax Assets, Deferred Interest Expense Deferred Tax Assets, Deferred Interest Expense Effect of Currency Translation Intangible Assets, Foreign Currency Translation Gain (Loss) Intangible Assets, Foreign Currency Translation Gain (Loss) Shareholders' equity, beginning balance (in shares) Shareholders' equity, ending balance (in shares) Shares, Issued Continuing operations (in dollars per share) Continuing operations, basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share Interest on lease liabilities Finance Lease, Interest Expense Accounts Payable and Accrued Liabilities Accounts Payable and Accrued Liabilities [Member] Machinery and equipment Machinery and equipment Machinery and Equipment [Member] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Principal amount of total long-term debt, less current portion, net Debt Instrument, Face Amount, Excluding Current Maturities Debt Instrument, Face Amount, Excluding Current Maturities Loss on capital assets Deferred Tax Assets, Capital Loss Carryforwards Revolving Credit Facility Revolving Credit Facility [Member] Schedule of Goodwill [Table] Schedule of Goodwill [Table] LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAX Total consolidated loss from continuing operations before income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Gain on extinguishment of debt Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost Outstanding, beginning balance (in dollars per share) Outstanding, ending balance (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Comprehensive Income Comprehensive Income, Policy [Policy Text Block] Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Abstract] Euro deferred shares, $0.01 par value; 4,000,000 shares authorized and issued at both December 31, 2020 and December 31, 2019 Euro Deferred Stock, Value, Issued Euro Deferred Stock, Value, Issued VASOSTRICT Related Matters VASOSTRICT Related Matters [Member] VASOSTRICT Related Matters [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Dilutive effect of ordinary share equivalents (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Proceeds from exercise of options Proceeds from Stock Options Exercised U.S. Federal Deferred Federal Income Tax Expense (Benefit) Restricted cash and cash equivalents Restricted Cash And Cash Equivalents [Member] Restricted Cash And Cash Equivalents [Member] Schedule of reportable segments information Schedule of Segment Reporting Information, by Segment [Table Text Block] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis] Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Generic Pharmaceuticals Generic Pharmaceuticals Generic Pharmaceuticals Segment [Member] Generic Pharmaceuticals Segment [Member] Income Statement [Abstract] Income Statement [Abstract] Other Established Other Established Products [Member] Other Established Products [Member] SUPPRELIN® LA SUPPRELIN LA [Member] SUPPRELIN LA [Member] Net identifiable assets acquired Asset Acquisition, Assets Acquired And Liabilities Assumed, Net Asset Acquisition, Assets Acquired And Liabilities Assumed, Net Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Prepaid and other assets Increase (Decrease) in Prepaid Expense and Other Assets Astora Astora [Member] Astora [Member] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Use of Estimates Use of Estimates, Policy [Policy Text Block] Lehigh Valley Technologies, Inc. acquisitions Lehigh Valley Technologies, Inc. [Member] Lehigh Valley Technologies, Inc. [Member] Income Tax Authority [Domain] Income Tax Authority [Domain] LTCI modification Stock Issued During Period, Value, Share-based Compensation, Modifications Stock Issued During Period, Value, Share-based Compensation, Modifications Cash paid for amounts included in the measurement of lease liabilities: Cash Flow, Lessee [Abstract] Cash Flow, Lessee [Abstract] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Foreign currency impact related to the remeasurement of intercompany debt instruments Adjustment for Long-term Intercompany Transactions, Gross of Tax Counterparty Name [Domain] Counterparty Name [Domain] Price per share of BioSpecifics Technologies Corp acquired (in dollars per shares) Asset Acquisition, Share Price Asset Acquisition, Share Price Capital expenditures, excluding capitalized interest Payments to Acquire Property, Plant, and Equipment Consolidation Items [Domain] Consolidation Items [Domain] Cash distributions to settle disputes from Qualified Settlement Funds Settlement Funds, Payments To Plaintiff Counsel From Qualified Settlement Funds Settlement Funds, Payments To Plaintiff Counsel From Qualified Settlement Funds Investments Asset Acquisition, Investments Asset Acquisition, Investments GOODWILL AND OTHER INTANGIBLES Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Reserve for loss contingencies Beginning balance Ending balance Loss Contingency Accrual Valuation Allowance [Table] Valuation Allowance [Table] Net (gain) loss from our investments in the equity of other companies Income (Loss) from Equity Method Investments Transaction costs Asset Acquisition, Transaction Costs Asset Acquisition, Transaction Costs Total segment adjusted income from continuing operations before income tax Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Federal income tax expense (benefit), continuing operations Effective Income Tax Rate Reconciliation, CARES Act, Amount Effective Income Tax Rate Reconciliation, CARES Act, Amount Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Accumulated impairment losses Goodwill, Impaired, Accumulated Impairment Loss Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Operating lease right-of-use assets Operating lease right-of-use asset impairment charges Operating Lease, Impairment Loss Schedule of inventory Schedule of Inventory, Current [Table Text Block] Summary of Tax Credit Carryforwards Summary of Tax Credit Carryforwards [Table Text Block] Entity [Domain] Entity [Domain] Branded Pharmaceuticals Branded Specialty and Established Pharmaceuticals [Member] Branded Specialty and Established Pharmaceuticals [Member] Payments of tax withholding for restricted shares Payment, Tax Withholding, Share-based Payment Arrangement Payments for debt issuance and extinguishment costs Payment For Debt Extinguishment Or Debt Prepayment Cost And Debt Issuance Costs Payment For Debt Extinguishment Or Debt Prepayment Cost And Debt Issuance Costs Long-term inventory Inventory, Noncurrent Restructuring and Related Costs Restructuring and Related Costs [Table Text Block] QUARTERLY FINANCIAL DATA (UNAUDITED) Quarterly Financial Information [Text Block] Statues of limitation Statues Of Limitation Statues Of Limitation Useful life Property, Plant and Equipment, Useful Life Changes in qualified settlement funds accounts and product liability balance Schedule of Loss Contingencies by Contingency [Table Text Block] Goodwill [Line Items] Goodwill [Line Items] Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Investment activities Effective Income Tax Rate Reconciliation, Investing Activities, Amount Effective Income Tax Rate Reconciliation, Investing Activities, Amount Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Accounts Payable and Accrued Liabilities, Current [Abstract] Accounts Payable and Accrued Liabilities, Current [Abstract] Upfront and milestone payments to partners Upfront And Milestone Payments To Partners Upfront and milestone payments to partners. Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Computer equipment and software Computer equipment and software Computer Equipment And Software [Member] Computer Equipment And Software [Member] License And Collaboration Agreements [Abstract] License And Collaboration Agreements [Abstract] License and Collaboration Agreements Abstract Summary of restricted and performance stock units activity Share-based Payment Arrangement, Activity [Table Text Block] Finished goods Inventory, Finished Goods, Net of Reserves Repurchased face amount Debt Instrument, Repurchased Face Amount Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Current portion of operating lease liabilities Current operating lease liabilities Operating Lease, Liability, Current Mesh product liability accrual Product Liability [Member] Product Liability [Member] Finance leases Right-of-Use Asset Obtained in Exchange for Finance Lease Liability Stock option assumption Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Employer matching contribution (percent) Defined Contribution Plan, Employer Matching Contribution, Percent of Match FAIR VALUE MEASUREMENTS Fair Value Disclosures [Text Block] Total unrecognized income tax benefits Total UTB balance including accrued interest and penalties Total Unrecognized Tax Benefits Including Interest And Penalties Total unrecognized tax benefits including interest and penalties. Customer [Domain] Customer [Domain] Cumulative Effect, Period of Adoption, Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Restricted Cash and Cash Equivalents, Insurance Coverage Restricted Cash And Cash Equivalents, Insurance Coverage [Member] Restricted Cash And Cash Equivalents, Insurance Coverage Entity Registrant Name Entity Registrant Name Subsequent Event Type [Domain] Subsequent Event Type [Domain] Accrued payroll and related benefits Accrued Employee Benefits, Current Operating leases Operating Lease, Weighted Average Discount Rate, Percent Assets: Assets, Fair Value Disclosure [Abstract] Accumulated amortization: Finite-Lived Intangible Assets, Accumulated Amortization [Roll Forward] Finite-Lived Intangible Assets, Accumulated Amortization [Roll Forward] Asset impairment charges Asset impairment charges Total Asset Impairment Charges Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Contract termination Contract Termination [Member] Less: amount representing interest Finance Lease, Liability, Undiscounted Excess Amount Effect of Currency Translation Finite-Lived Intangible Assets, Translation Adjustments, Effect On Accumulated Amortization Finite-Lived Intangible Assets, Translation Adjustments, Effect On Accumulated Amortization Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Other Finite-Lived Intangible Assets, Other, Effect On Accumulated Amortization Finite-Lived Intangible Assets, Other, Effect On Accumulated Amortization Beginning liability balance Ending liability balance Restructuring Reserve Adjustments for New Accounting Pronouncements [Axis] Accounting Standards Update [Axis] Schedule of cash and cash equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Mesh Liability Accrual Loss Contingency Accrual [Roll Forward] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Entity Address, Postal Zip Code Entity Address, Postal Zip Code After Non-call Period Debt Instrument, Redemption, Period Two [Member] Depreciation and amortization Disposal Group, Including Discontinued Operation, Depreciation and Amortization Restructuring Type [Axis] Restructuring Type [Axis] Net unrealized gain (loss) on foreign currency Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Restructuring Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block] GOODWILL Goodwill, beginning balance Goodwill, ending balance Goodwill Total other comprehensive income (loss) Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 5.875% Senior Secured Notes due 2024 Five Point Eight Seven Five Percent Senior Secured Notes Due Twenty Twenty Four [Member] Five Point Eight Seven Five Percent Senior Secured Notes Due Twenty Twenty Four [Member] Acquisitions, including in-process research and development, net of cash and restricted cash acquired Payments To Acquire Businesses And Asset Acquisitions, Net Of Cash Acquired Payments To Acquire Businesses And Asset Acquisitions, Net Of Cash Acquired Net operating loss carryforward Deferred Tax Assets, Operating Loss Carryforwards Restructuring costs and asset impairment charges Restructuring Costs and Asset Impairment Charges Principal Amount Principal amount Debt Instrument, Face Amount Discount rate applied Business Combination, Contingent Consideration, Liability, Measurement Input Schedule of changes in the carrying amount of goodwill Schedule of Goodwill [Table Text Block] Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period EQUITY: Equity [Abstract] Fair value of financial assets measured on recurring basis Total Assets, Fair Value Disclosure Upfront payment related to development, license and commercialization agreement Collaboration Arrangements, Upfront Payment, Development, License And Commercialization Agreement Collaboration Arrangements, Upfront Payment, Development, License And Commercialization Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] DISCONTINUED OPERATIONS Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Schedule of other intangible assets Schedule of Intangible Assets and Goodwill [Table Text Block] Contract liability amounts classified as current Contract with Customer, Liability, Current Intangible assets—in-process research and development Acquisitions Indefinite-lived Intangible Assets Acquired Trade accounts payable Accounts Payable, Trade, Current Accounting Standards Update [Extensible List] Accounting Standards Update [Extensible List] Asset acquisition, intangible asset expense Asset Acquisition, Intangible Asset Expense Asset Acquisition, Intangible Asset Expense Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Performance Stock Units Performance Stock Units [Member] Performance Stock Units [Member] Customer Concentration Risk Customer Concentration Risk [Member] Schedule of future amortization expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Diluted (in shares) For diluted per share data—weighted average shares (in shares) Weighted average shares—Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Schedule of accounts payable and accrued liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Debt Disclosure [Abstract] Debt Disclosure [Abstract] Ireland Revenue Commissioners, Ireland [Member] LTCI modification (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, LTCI Modification Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, LTCI Modification Restructuring Plan [Axis] Restructuring Plan [Axis] Amortization of debt issuance costs and discount Amortization of Debt Issuance Costs and Discounts 2017 credit agreement 2017 Credit Agreement [Member] 2017 Credit Agreement [Member] 6.00% Senior Notes due 2028 Six Percent Senior Notes Due 2028 [Member] Six Percent Senior Notes Due 2028 Repayments of debt Repayments of Long-term Debt Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Intrinsic Value, Amount Per Share [Abstract] Term Loan Facility Term Loan B Facility Due Two Thousand Twenty Four [Member] Term Loan B Facility Due Two Thousand Twenty Four [Member] Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Current unrecognized tax benefit Unrecognized tax benefits, beginning balance Unrecognized tax benefits, ending balance Unrecognized Tax Benefits Counterparty Name [Axis] Counterparty Name [Axis] Ordinary shares, $0.0001 par value; 1,000,000,000 shares authorized; 230,315,768 and 226,802,609 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively Common Stock, Value, Issued Document Fiscal Year Focus Document Fiscal Year Focus Other comprehensive income (loss), tax, portion attributable to parent Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent 2022 Finite-Lived Intangible Asset, Expected Amortization, Year Two Increase in excess inventory reserves Increase In Excess Inventory Reserves [Member] Increase In Excess Inventory Reserves Right-of-use assets: Assets, Noncurrent [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Current portion of long-term debt Less current portion, net Long-term Debt, Current Maturities 6.00% Senior Notes due 2025 Six Percent Senior Notes Due 2025 [Member] Six Percent Senior Notes Due 2025 [Member] Entity Current Reporting Status Entity Current Reporting Status Changes in fair value recorded in earnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9.50% Senior Secured Second Lien Notes due 2027 Nine Point Five Percent Senior Notes Due 2027 [Member] Nine Point Five Percent Senior Notes Due 2027 Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Certain other charges Certain Other Charges [Member] Certain Other Charges [Member] LICENSE AND COLLABORATION AGREEMENTS Collaborative Arrangement Disclosure [Text Block] Common stock, shares issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Number of cases filed by states Loss Contingency, Claims Filed By States, Number Loss Contingency, Claims Filed By States, Number Total operating lease liabilities Total operating lease liabilities Operating Lease, Liability Net deferred income tax liability Deferred Tax Liabilities, Net LONG-TERM DEBT, LESS CURRENT PORTION, NET Carrying amount of total long-term debt, less current portion, net Long-term Debt, Excluding Current Maturities Segment Reporting [Abstract] Segment Reporting [Abstract] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Debt Instrument [Line Items] Debt Instrument [Line Items] Total equity Shareholders' equity, beginning balance Shareholders' equity, ending balance Cumulative effect period of adoption Stockholders' Equity Attributable to Parent Residual tax on non-U.S. net earnings Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Cash contributions to Qualified Settlement Funds Settlement Funds, Cash Contributions To Qualified Settlement Funds Settlement Funds, Cash Contributions To Qualified Settlement Funds Repayments of term loans Repayments of Other Long-term Debt Entity Address, City or Town Entity Address, City or Town Fair Value, Liabilities Measured on Recurring Basis, Disclosure Items [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Asset Acquisitions Asset Acquisitions, Policy [Policy Text Block] Asset Acquisitions, Policy Accounts payable and accrued expenses Total Accounts Payable and Accrued Liabilities, Current 2025 Lessee, Operating Lease, Liability, to be Paid, Year Five Employee separation, continuity and other benefit-related costs Restructuring And Related Cost, Employee Costs Restructuring And Related Cost, Employee Costs Financial Instrument [Axis] Financial Instrument [Axis] Type of Adoption [Domain] Accounting Standards Update [Domain] Corporate unallocated costs Segment Reporting Information, Unallocated Corporate Expense Segment Reporting Information, Unallocated Corporate Expense Acquisitions Intangible Assets Acquired Intangible Assets Acquired Savings And Investment Plan And Deferred Compensation [Line Items] Savings And Investment Plan And Deferred Compensation [Line Items] Savings And Investment Plan And Deferred Compensation [Line Items] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Acquisition-related contingent consideration Acquisition Related Contingent Consideration [Member] Acquisition-Related Contingent Consideration [Member] Valuation allowance Valuation allowance Deferred Tax Assets, Valuation Allowance Liabilities: Liabilities [Abstract] ACQUISITIONS Asset Acquisition Disclosure [Text Block] Asset Acquisition Disclosure Loss contingency, claims settled, number Loss Contingency, Claims Settled, Number 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Three License And Collaboration Agreements [Table] License And Collaboration Agreements [Table] License And Collaboration Agreements [Table] Less: royalty obligations discharged Asset Acquisition, Consideration Transferred, Royalty Obligations Discharged Asset Acquisition, Consideration Transferred, Royalty Obligations Discharged Revenue from Contract with Customer Revenue from Contract with Customer [Policy Text Block] Noncurrent finance lease liabilities Finance Lease, Liability, Noncurrent Leases [Abstract] Leases [Abstract] Share Repurchases Treasury Stock [Policy Text Block] Treasury Stock Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Earnings Per Share [Abstract] Earnings Per Share [Abstract] Operating loss carryforwards Operating Loss Carryforwards Income Tax Authority, Name [Axis] Income Tax Authority, Name [Axis] Restructuring charges Restructuring Charges Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total property, plant and equipment, gross Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Allowances for sales returns and allowances Allowances for Sales Returns and Allowances Allowances for Sales Returns and Allowances Gain on sale of business and other assets Gain (Loss) on Disposition of Business Disposal Group Name [Domain] Disposal Group Name [Domain] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Fiscal Period Focus Document Fiscal Period Focus Other Intangible Assets [Line Items] Other Intangible Assets [Line Items] Other Intangible Assets [Line Items] Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table] Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments [Table] Asset Acquisition [Domain] Asset Acquisition [Domain] Asset Acquisition Accrued royalties and other distribution partner payables Accrued Royalties and Other Distribution Partner Payables, Current Accrued Royalties and Other Distribution Partner Payables, Current SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table] Litigation-related and other contingencies, net Gain (Loss) Related to Litigation Settlement Inventories not yet available for sale Inventory, Not Yet Available For Sale, Net Inventory, Not Yet Available For Sale, Net Other acquisitions, excluding Voltaren Other Acquisitions, Excluding Voltaren [Member] Other Acquisitions, Excluding Voltaren Currency translation adjustment Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation Redemption price (as percent) Debt Instrument, Redemption Price, Percentage Entity Filer Category Entity Filer Category Schedule of allocation of stock-based compensation Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Ordinary Shares Common Stock [Member] Product and Service [Domain] Product and Service [Domain] Schedule of Asset Acquisition [Table] Schedule of Asset Acquisition [Table] Schedule of Asset Acquisition Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Contributions towards defined contribution savings and investment plans Defined Contribution Plan, Cost Finance leases Finance Lease, Weighted Average Discount Rate, Percent Premium on an expiring insurance program Premium On An Expiring Insurance Program [Member] Premium On An Expiring Insurance Program Term Loan Facility Secured Debt [Member] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Total other intangibles Intangible Assets, Gross [Roll Forward] Intangible Assets, Gross [Roll Forward] Assets under construction Asset under Construction [Member] Leasehold improvements Leasehold Improvements [Member] Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Interest rate Debt Instrument, Interest Rate, Stated Percentage Corresponding liability Deferred Compensation Share-based Arrangements, Liability, Current Unamortized discount (premium) and debt issuance costs, net Write off of Deferred Debt Issuance Cost NET INCOME (LOSS) PER SHARE—DILUTED: Earnings Per Share, Diluted [Abstract] Research and development and other tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards, Research Exercise of options (in shares) Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Other (income) expense, net Other (income) expense, net Nonoperating Income (Expense) Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Stock Options Share-based Payment Arrangement, Option [Member] COSTS AND EXPENSES: Costs and Expenses [Abstract] Deferred: Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract] AmerisourceBergen Corporation Amerisource Bergen Corporation [Member] Amerisource Bergen Corporation [Member] U.S. State Deferred State and Local Income Tax Expense (Benefit) Employee severance Employee Severance [Member] 2025 Long-Term Debt, Maturity, Year Five U.S. Income (Loss) from Continuing Operations before Income Taxes, Domestic Cash paid for interest, excluding capitalized interest Interest Paid, Excluding Capitalized Interest, Operating Activities Savings And Investment Plan And Deferred Compensation Plans [Abstract] Savings And Investment Plan And Deferred Compensation Plans [Abstract] Savings And Investment Plan And Deferred Compensation Plans [Abstract] Maturities Long-term Debt, Fiscal Year Maturity [Abstract] Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items] DESCRIPTION OF BUSINESS Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Additional paid-in capital Additional Paid in Capital 2021 Finite-Lived Intangible Asset, Expected Amortization, Year One Proceeds from sale of business and other assets, net Proceeds from Divestiture of Businesses Intangible assets, excluding goodwill Impairments Other intangible asset impairment charges Impairment of Intangible Assets (Excluding Goodwill) Quarterly Financial Data [Abstract] Quarterly Financial Data [Abstract] Fair value of financial liabilities measured on recurring basis Financial and Nonfinancial Liabilities, Fair Value Disclosure Diluted (in dollars per share) Earnings Per Share, Diluted Schedule of Unrecognized Tax Benefits Roll Forward Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] XIAFLEX® Xiaflex [Member] Xiaflex [Member] Opioid-related matters Opioid-Related Matters [Member] Opioid-Related Matters [Member] Number of cases set for trial Loss Contingency, Cases Set For Trial, Number Loss Contingency, Cases Set For Trial, Number Schedule of long-term debt instruments Schedule of Long-term Debt Instruments [Table Text Block] Increase in contract liability Contract with Customer, Liability, Increase (Decrease) Contract with Customer, Liability, Increase (Decrease) Depreciation expense Total depreciation expense Depreciation Entity Address, Address Line One Entity Address, Address Line One Qualified Settlement Funds Settlement Funds [Roll Forward] Settlement Funds [Roll Forward] Entity Emerging Growth Company Entity Emerging Growth Company Beginning Balance Ending Balance Indefinite-lived Intangible Assets (Excluding Goodwill) Total deferred income tax Deferred Income Tax Expense (Benefit) Intangible assets, excluding goodwill Finite-lived Intangible Assets, Fair Value Disclosure Sterile Injectables Sterile Injectables Sterile Injectables Segment [Member] Sterile Injectables Segment [Member] Certain litigation-related and other contingencies, net Loss Contingency, Loss in Period TESTOPEL® Lidoderm [Member] Lidoderm [Member] Accumulated Amortization Beginning Balance Ending Balance Finite-Lived Intangible Assets, Accumulated Amortization Maximum Maximum [Member] Cash used in investing activities Cash Provided by (Used in) Investing Activities, Discontinued Operations Rebates Accrued Liabilities, Rebates Accrued Liabilities, Rebates Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Revenue from contract with customer, return period Revenue From Contract With Customer, Return Period Revenue From Contract With Customer, Return Period Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Product acquisition costs and license fees Payments For Product Acquisition Costs And License Fees Payments For Product Acquisition Costs And License Fees Investments [Domain] Investments [Domain] Trading Symbol Trading Symbol Amounts Settled and Other Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements And Effect Of Currency Translation Fair Value, Measurement With Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements And Effect Of Currency Translation Denominator: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Summary of Valuation Allowance Summary of Valuation Allowance [Table Text Block] Contract assets, net Contract with Customer, Asset, after Allowance for Credit Loss Colchicine Tablets Colchicine Tablets [Member] Colchicine Tablets [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Stock Award Stock Award [Member] Stock Award [Member] International Income (Loss) from Continuing Operations before Income Taxes, Foreign Entity Shell Company Entity Shell Company Debt Instrument Redemption [Table] Debt Instrument Redemption [Table] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Fair value, measurements, recurring Fair Value, Recurring [Member] 2022 Finance Lease, Liability, to be Paid, Year Two Expired (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Other Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Entity Public Float Entity Public Float Other assumed liabilities Asset Acquisition, Other Liabilities Asset Acquisition, Other Liabilities Acquisitions and Contingent Consideration Business Combinations Policy [Policy Text Block] Inventory step-up Inventory Step Up Inventory Step Up Document Type Document Type ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Other miscellaneous, net Other Nonoperating Income (Expense) Net gain on sale of business and other assets Gain (Loss) Disposition Of Business And Other Assets Gain (Loss) Disposition Of Business And Other Assets Target amount of share-based compensation awards, stock options (in shares) Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Reporting Unit [Axis] Reporting Unit [Axis] International Pharmaceuticals International Pharmaceuticals [Member] International Pharmaceuticals [Member] Accounts payable, accrued expenses and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Product Information [Line Items] Product Information [Line Items] Segments [Axis] Segments [Axis] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain] In-process research and development In Process Research and Development [Member] Level 3 Inputs Fair Value, Inputs, Level 3 [Member] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Lease Accounting Lessee, Leases [Policy Text Block] Uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Contingency, Amount Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] DEFERRED INCOME TAXES Deferred Income Tax Liabilities, Net OTHER INTANGIBLES, NET Net other intangibles Intangible Assets, Net (Excluding Goodwill) Other Settlement Funds, Other Settlement Funds, Other Euro deferred shares, par value (in dollars per share) Euro Deferred Shares, Par or Stated Value Per Share Euro Deferred Shares, Par or Stated Value Per Share Employee separation, continuity and other benefit-related costs Severance Costs Long-Lived Asset Impairment Testing Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block] Contract assets and liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Variable Rate [Axis] Variable Rate [Axis] COMMITMENTS AND CONTINGENCIES (NOTE 16) Commitments and Contingencies Maximum annual contributions per employee (percent) Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Tax withholding for restricted shares Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Tranche Two Share-based Payment Arrangement, Tranche Two [Member] Schedule of components of other income, net Schedule of Other Nonoperating Income, by Component [Table Text Block] Vesting period Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Furniture and fixtures Furniture and fixtures Furniture and Fixtures [Member] Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Notional U.S. federal income tax provision at the statutory rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Effect of currency translation Goodwill, Foreign Currency Translation Gain (Loss) Numerator: Earnings Per Share Reconciliation [Abstract] Sublease income Sublease Income Royalty rate on net sales License Agreement, Royalty Rate, Percentage of Net Sales License Agreement, Royalty Rate, Percentage of Net Sales Accumulated deficit Retained Earnings (Accumulated Deficit) Debt Instrument, Redemption [Line Items] Debt Instrument, Redemption [Line Items] OPERATING LEASE ASSETS Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Acquisition-related contingent consideration—current Acquisition Related Contingent Consideration Short Term [Member] Acquisition Related Contingent Consideration-Short Term [Member] Gain on extinguishment of debt Gain on extinguishment of debt Gain (loss) on extinguishment of debt Gain (Loss) on Extinguishment of Debt Product Concentration Risk Product Concentration Risk [Member] Charges to increase excess inventory reserves Restructuring And Related Cost, Increase In Excess Inventory Reserves Restructuring And Related Cost, Increase In Excess Inventory Reserves Cash paid for income taxes, gross Income Taxes Paid 2021 Finance Lease, Liability, to be Paid, Year One SHAREHOLDERS' DEFICIT: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Customer [Axis] Customer [Axis] Credit Concentration Risk Credit Concentration Risk [Member] Effect of Currency Translation Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Currency translation adjustment Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation Income Taxes Income Tax, Policy [Policy Text Block] Lease, cost Lease, Cost Endo 401(k) Plan, Matching Tier One Endo 401(k) Plan, Matching Tier One [Member] Endo 401(k) Plan, Matching Tier One [Member] Exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Nonvested Stock Options Non Vested Stock Options [Member] Non Vested Stock Options [Member] Other investing activities Payments for (Proceeds from) Other Investing Activities Paladin labs inc. Paladin Labs Inc. [Member] Paladin Labs Inc. [Member] Lawsuit filing period Loss Contingency, Lawsuit Filing Period Loss Contingency, Lawsuit Filing Period Finite-lived intangible assets, reclassification adjustment Finite-Lived Intangible Assets, Reclassification Adjustment Finite-Lived Intangible Assets, Reclassification Adjustment Executive compensation limitation Effective Income Tax Rate Reconciliation, Executive Compensation Limitation, Amount Effective Income Tax Rate Reconciliation, Executive Compensation Limitation, Amount 5.375% Senior Notes due 2023 Five Point Three Seven Five Senior Notes Due On Two Thousand Twenty Three [Member] Five Point Three Seven Five Senior Notes Due On Two Thousand Twenty Three [Member] Cumulative Effect, Period of Adoption, Adjusted Balance Cumulative Effect, Period of Adoption, Adjusted Balance [Member] TOTAL REVENUES, NET Total net revenues from external customers Revenue from Contract with Customer, Excluding Assessed Tax Advertising expense Advertising Expense Business Acquisition [Axis] Business Acquisition [Axis] Geographical [Domain] Geographical [Domain] ADRENALIN® Adrenalin [Member] Adrenalin [Member] Vaginal mesh cases Vaginal Mesh Cases [Member] Vaginal Mesh Cases [Member] International Deferred Foreign Income Tax Expense (Benefit) Total segment adjusted income from continuing operations before income tax Total segment adjusted income from continuing operations before income tax Adjusted Income (Loss) Before Income Tax Adjusted income (loss) before income tax. Long-term Cash Incentive Long-term Cash Incentive [Member] Long-term Cash Incentive [Member] Proceeds from long-term lines of credit Proceeds from Long-term Lines of Credit Quarter periodic payment, percent Debt Instrument, Quarterly Periodic Payment, Percent Debt Instrument, Quarterly Periodic Payment, Percent Accrued interest Interest Payable, Current Entity Voluntary Filers Entity Voluntary Filers PERCOCET® PERCOCET [Member] PERCOCET [Member] Acquisition-related and integration items, net Acquisition-related costs Business Combination, Acquisition Related Costs Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Credit Facility [Axis] Credit Facility [Axis] Other Other Acquisitions [Member] Other Acquisitions [Member] 7.25% Senior Notes due 2022 Seven Point Two Five Percent Senior Notes Due Two Thousand Twenty Two [Member] Seven Point Two Five Percent Senior Notes Due Two Thousand Twenty Two [Member]. Stay of approval period, Hatch-Waxman Act Loss Contingency, Stay Of Approval Period, Hatch-Waxman Act Loss Contingency, Stay Of Approval Period, Hatch-Waxman Act Foreign Foreign Tax Authority [Member] Number of registered shareholders Number of Registered Shareholders Number of Registered Shareholders Note repurchases Note Repurchases [Member] Note Repurchases [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Retirement Plan Name [Domain] Retirement Plan Name [Domain] Litigation-related and other contingencies, net Disposal Group, Including Discontinued Operation, Litigation Related And Other Contingencies Disposal Group Including Discontinued Operation, Litigation Related And Other Contingencies Capital Loss Carryforward Capital Loss Carryforward [Member] Operating Leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Ertapenem for injection Ertapenem For Injection [Member] Ertapenem For Injection [Member] Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Non-Call Period Debt Instrument, Redemption, Period One [Member] Selling, general and administrative Selling, General and Administrative Expenses [Member] Goodwill [Roll Forward] Goodwill [Roll Forward] Intra-entity transfers of assets Effective Income Tax Rate Reconciliation, Intra-Entity Transfers of Assets Other Than Inventory, Amount Effective Income Tax Rate Reconciliation, Intra-Entity Transfers of Assets Other Than Inventory, Amount Reconciliation of the numerator and denominator of basic and diluted net loss per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Income taxes payable/receivable, net Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable Contingent Consideration Type [Domain] Contingent Consideration Type [Domain] LEASES Lessee, Finance Leases [Text Block] Research and Development Expense Research and Development Expense, Policy [Policy Text Block] Payments to plaintiffs and qualified settlement funds Loss Contingency Accrual, Payments Repayments of other indebtedness Repayments of Debt VOLTAREN® Gel Voltaren Gel [Member] Voltaren Gel [Member] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Asset Acquisition [Axis] Asset Acquisition [Axis] Asset Acquisition Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Asset impairment charges Asset Impairment Charges, Including Continuing and Discontinued Operations Asset Impairment Charges, Including Continuing and Discontinued Operations Senior notes Senior Notes [Member] Income taxes receivable Income Taxes Receivable, Current Geographical [Axis] Geographical [Axis] Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Finance lease liabilities: Assets and Liabilities, Lessee [Abstract] Segments [Domain] Segments [Domain] Weighted average remaining requisite service period, non-vested stock options Weighted Average Remaining Requisite Service Period Of Non Vested Stock Options Weighted Average Remaining Requisite Service Period Of Non Vested Stock Options Number of cases alleging personal injury and/or wrongful death Loss Contingency, Number Of Cases Alleging Personal Injury And/Or Wrongful Death Loss Contingency, Number Of Cases Alleging Personal Injury And/Or Wrongful Death Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Employee separation, retention and other benefit-related costs Employee Severence and Other Benefit Related Costs [Member] Employee Severence and Other Benefit Related Costs [Member] 2024 Long-Term Debt, Maturity, Year Four Other Sterile Injectables Other Sterile Injectables [Member] Other Sterile Injectables [Member] Total right-of-use assets Lease, Right-of-Use Asset Lease, Right-of-Use Asset Income Statement Location [Axis] Income Statement Location [Axis] Entity Ordinary Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Commitments not extended Debt Instrument, Commitments Not Extended, Amount Debt Instrument, Commitments Not Extended, Amount Non-deductible goodwill impairment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount U.S. Federal Current Federal Tax Expense (Benefit) Amortization of intangible assets Amortization Amortization of intangible assets Amortization of Intangible Assets Line of Credit Facility [Table] Line of Credit Facility [Table] Lease liabilities arising from obtaining right-of-use assets: Lease Liabilities Arising from Obtaining Right-of-Use Assets [Abstract] Lease Liabilities Arising from Obtaining Right-of-Use Assets Cash refunds from income taxes, gross Proceeds from income tax refunds Proceeds from Income Tax Refunds SEGMENT RESULTS Segment Reporting Disclosure [Text Block] Ordinary shares issued Stock Issued During Period, Value, New Issues Operating cash payments for finance leases Finance Lease, Interest Payment on Liability Revenue from Contract with Customer Benchmark Revenue from Contract with Customer Benchmark [Member] McKesson Corporation Mckesson Corporation [Member] McKesson Corporation [Member] Title of 12(b) Security Title of 12(b) Security Disposal Group Classification [Axis] Disposal Group Classification [Axis] Generic Pharmaceuticals Generic Pharmaceuticals [Member] Generic Pharmaceuticals [Member] Loss from discontinued operations before income taxes Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax Net Book Amount Finite-Lived Intangible Assets, Net Options granted, weighted average grant date fair value (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Income taxes payable Accrued Income Taxes, Current Cash distributions to settle disputes Loss Contingency Accrual, Payments To Plaintiff Counsel Loss Contingency Accrual, Payments To Plaintiff Counsel Vesting [Domain] Vesting [Domain] Finance Lease, Liability, Fiscal Year Maturity Finance Lease, Liability, Fiscal Year Maturity [Table Text Block] Interest expense, net Interest Expense Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Other Stockholders' Equity, Other Schedule of Components of Income Tax Expense (Benefit) Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Long-term debt, maturity repayment deadline Long-term Debt, Maturity Repayment Deadline Long-term Debt, Maturity Repayment Deadline Product and Service [Axis] Product and Service [Axis] Investment Type [Axis] Investment Type [Axis] Certain property, plant and equipment Property, Plant, and Equipment, Fair Value Disclosure Weighted average remaining requisite service period, non-vested restricted stock units Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 2025 Finance Lease, Liability, to be Paid, Year Five Proceeds from issuance of notes, net Proceeds from Notes Payable Certain other restructuring costs Other restructuring charges Other Restructuring [Member] 2022 Long-Term Debt, Maturity, Year Two Cloud Computing Arrangements Hosting Arrangement Service Contract [Policy Text Block] Hosting Arrangement Service Contract Accelerated depreciation charges Accelerated Depreciation Charges [Member] Accelerated Depreciation Charges Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Table] Fair Value, Recurring and Nonrecurring [Table] Settlement funds Beginning balance Ending balance Settlement Funds Settlement Funds Raw materials Inventory, Raw Materials, Net of Reserves Discontinued operations (in dollars per share) Discontinued operations, basic (in dollars per share) Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share Outstanding, end of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Debt Instrument [Axis] Debt Instrument [Axis] Schedule of Quarterly Financial Information Quarterly Financial Information [Table Text Block] Operating segments Operating Segments [Member] Contingent Consideration by Type [Axis] Contingent Consideration by Type [Axis] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Treasury stock, value, acquired, cost method Treasury Stock, Value, Acquired, Cost Method Adjustments to reconcile Net income (loss) to Net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Litigation Case [Axis] Litigation Case [Axis] Variable lease costs Variable Lease, Cost State income tax, net of federal benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount Cost basis: Other Intangible Assets, Cost Basis [Abstract] Other Intangible Assets, Cost Basis [Abstract] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Research and development Research and Development Expense Subsequent event Subsequent Event [Member] Branded Pharmaceuticals Branded Pharmaceuticals Branded Pharmaceuticals Segment [Member] Branded Pharmaceuticals Segment [Member] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Restructuring Plan [Domain] Restructuring Plan [Domain] 2015 Share Buyback Program Member 2015 Share Buyback Program [Member] 2015 Share Buyback Program Business acquisition, equity interest canceled, not tendered (in shares) Asset Acquisition, Equity Interest Canceled, Not Tendered Asset Acquisition, Equity Interest Canceled, Not Tendered Asset impairment charges of long-lived assets Impairment of Long-Lived Assets Held-for-use Cash and cash equivalents Asset Acquisition, Cash And Equivalents Asset Acquisition, Cash And Equivalents Vesting period Defined Contribution Plan, Employers Matching Contribution, Vesting Term Defined Contribution Plan, Employers Matching Contribution, Vesting Term Net gain on sale of business and other assets Gain (Loss) on Disposition of Assets Service period Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Repayments of senior debt Repayments of Senior Debt OPERATING LEASE LIABILITIES, LESS CURRENT PORTION Noncurrent operating lease liabilities Operating Lease, Liability, Noncurrent 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Four Payments of debt restructuring costs Payments of Debt Restructuring Costs Operating leases, rent expense Operating Leases, Rent Expense CURRENT ASSETS: Assets, Current [Abstract] Equity based compensation Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount Deferred tax liability Asset Acquisition, Deferred Tax Liabilities Asset Acquisition, Deferred Tax Liabilities COMPREHENSIVE INCOME (LOSS) Comprehensive Income (Loss), Net of Tax, Attributable to Parent 2023 Finance Lease, Liability, to be Paid, Year Three Dividend yield Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] 2021 Long-Term Debt, Maturity, Year One Euro deferred shares, shares issued (in shares) Euro Deferred Shares, Shares Issued Euro Deferred Shares, Shares Issued Deductions, Write-offs SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Legal Entity [Axis] Legal Entity [Axis] City Area Code City Area Code Income Tax Authority [Axis] Income Tax Authority [Axis] Document Period End Date Document Period End Date Finite-lived intangibles: Finite-lived Intangible Assets [Roll Forward] Stock repurchase program, authorized amount Stock Repurchase Program, Authorized Amount Net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Disaggregation of revenue Disaggregation of Revenue [Table Text Block] Total acquisition consideration Asset Acquisition, Consideration Transferred Asset Acquisition, Consideration Transferred Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Share-based compensation Share-based Payment Arrangement, Noncash Expense Performance target term Share-based Compensation Arrangement by Share-based Payment Award, Performance Target Term Share-based Compensation Arrangement by Share-based Payment Award, Performance Target Term Cover [Abstract] Cover [Abstract] Base Rate Base Rate [Member] Other Specialty Other Specialty Products [Member] Other Specialty Products [Member] Measurement Input Type [Axis] Measurement Input Type [Axis] Percentage of employees gross pay Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Current: Current Federal, State and Local, Tax Expense (Benefit) [Abstract] Schedule of Income before Income Tax, Domestic and Foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Huntsville, Alabama manufacturing and distributing facility Huntsville, Alabama Manufacturing and Distributing Facility [Member] Huntsville, Alabama Manufacturing and Distributing Facility [Member] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Carrying Amount Aggregate carrying amount Long-term Debt Contract liabilities, net - $ change Increase (Decrease) in Contract with Customer, Liability Net gain on disposal Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax LEASES Lessee, Operating Leases [Text Block] Discount rate applied Intangible assets and goodwill, measurement input Intangible Assets, Net, (Including Goodwill), Measurement Input Intangible Assets, Net, (Including Goodwill), Measurement Input Schedule of Asset Acquisition [Line Items] Schedule of Asset Acquisition [Line Items] Schedule of Asset Acquisition Euro deferred shares, shares authorized (in shares) Euro Deferred Shares, Shares Authorized Euro Deferred Shares, Shares Authorized Retirement Plan Name [Axis] Retirement Plan Name [Axis] OTHER (INCOME) EXPENSE, NET Other Income and Other Expense Disclosure [Text Block] Merger Agreement Merger Agreement [Member] Merger Agreement Cardinal Health, Inc. Cardinal Health Inc [Member] Cardinal Health Inc [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Finance lease cost: Lease, Cost [Abstract] DISCONTINUED OPERATIONS, NET OF TAX (NOTE 3) Loss from discontinued operations, net of tax Loss from discontinued operations, net of tax Discontinued operations, net of tax Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Equity Components [Axis] Equity Components [Axis] Pending claims, number Loss Contingency, Pending Claims, Number Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Total gross deferred income tax assets Deferred Tax Assets, Gross Minimum Minimum [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Other cash distributions for mesh legal settlements Other Payments For Legal Settlements Other Payments For Legal Settlements PROPERTY, PLANT AND EQUIPMENT, NET Total property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization General Business Tax Credit Carryforward General Business Tax Credit Carryforward [Member] Repayments of notes Repayments of Notes Payable Income Tax Authority, Name [Domain] Income Tax Authority, Name [Domain] Other Finite-lived Intangible Assets, Other Finite-lived Intangible Assets, Other Entity Interactive Data Current Entity Interactive Data Current Domestic Domestic UNITED STATES Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Restrictions on cash and cash equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] SHAREHOLDERS' DEFICIT Stockholders' Equity Note Disclosure [Text Block] Summary of activity under stock incentive plans Share-based Payment Arrangement, Option, Activity [Table Text Block] Share-Based Compensation Share-based Payment Arrangement [Policy Text Block] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Weighted average remaining lease term (years), weighted based on lease liability balances: Sales-type Lease, Net Investment in Lease [Abstract] Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] International Current Foreign Tax Expense (Benefit) Contract liabilities, net - % change Contract with Customer, Liability, Increase (Decrease), Percentage Contract with Customer, Liability, Increase (Decrease), Percentage 2020 Restructuring Initiative Restructuring Initiative, 2020 [Member] Restructuring Initiative, 2020 Settlement, amount awarded to other party Litigation Settlement, Amount Awarded to Other Party Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Total gross deferred income tax liabilities Deferred Tax Liabilities, Gross International Pharmaceuticals International Pharmaceuticals International Pharmaceuticals Segment [Member] International Pharmaceuticals Segment [Member] Advertising Cost Advertising Cost [Policy Text Block] Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Component of Operating Income [Abstract] Component of Operating Income [Abstract] Beginning balance Ending balance Intangible Assets, Gross (Excluding Goodwill) Customer Product And Supplier Concentration Customer Product And Supplier Concentration [Policy Text Block] Customer Product And Supplier Concentration Base erosion minimum tax Effective Income Tax Rate Reconciliation, Tax Cuts and Jobs Act, Amount Number of reportable segments Number of Reportable Segments Returns and allowances Accrued Liabilities Returns And Allowances Accrued liabilities returns and allowances. Change in fair value of contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Additions, Costs and Expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Effective Interest Rate Debt Instrument, Interest Rate, Effective Percentage Research and development Research and Development Expense [Member] Consolidation Items [Axis] Consolidation Items [Axis] Goodwill impairment charges Goodwill impairment charges Goodwill impairment charges Goodwill, Impairment Loss Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Total future lease payments Lessee, Operating Lease, Liability, to be Paid Other Deferred Tax Assets, Other Number of putative class actions Loss Contingency, Number Of Putative Class Actions Loss Contingency, Number Of Putative Class Actions Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Other lease costs and income: Operating Lease, Lease Income [Abstract] CARES Act CARES Act [Member] CARES Act Foreign Currency Foreign Currency Transactions and Translations Policy [Policy Text Block] Chargebacks Accrued Liabilities Chargebacks Accrued liabilities chargebacks. Cash payments Payments for restructuring Payments for Restructuring Disposal group, disposed of by sale, not discontinued operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] PSU award percentage using free cash flow performance metric Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Free Cash Flow Performance Metric, Grants in Period, Percentage Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other than Options, Free Cash Flow Performance Metric, Grants In Period, Percentage Number of customers Number Of Customers Number Of Customers Document Transition Report Document Transition Report Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Tax benefit from exercise of stock options Share-based Payment Arrangement, Exercise of Option, Tax Benefit Acquisition-related contingent consideration—current Business Combination, Contingent Consideration, Liability, Current Vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested and Expected to Vest Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested and Expected to Vest Restricted cash and cash equivalents Restricted cash and cash equivalents, current Restricted Cash and Cash Equivalents, Current Level 2 Inputs Fair Value, Inputs, Level 2 [Member] Summary of nonrecurring fair value measurements Fair Value Measurements, Nonrecurring [Table Text Block] Asset Acquisition [Abstract] Asset Acquisition Vesting [Axis] Vesting [Axis] Weighted average discount rate (percentages), weighted based on the remaining balance of lease payments: Direct Financing Lease, Net Investment in Leases [Abstract] Number of sterile injectable product candidates Number of Sterile Injectable Product Candidates Number of Sterile Injectable Product Candidates Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Vested and expected to vest (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Credit Facility [Domain] Credit Facility [Domain] Number of former employees Number Of Former Employees Number Of Former Employees Litigation Case [Domain] Litigation Case [Domain] Basic (in dollars per share) Earnings Per Share, Basic Unrecognized tax benefits that would impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Public Employees' Retirement System of Mississippi vs. Endo International PLC Public Employees' Retirement System of Mississippi vs. Endo International PLC [Member] Public Employees' Retirement System of Mississippi vs. Endo International PLC [Member] Entity File Number Entity File Number Expired (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Operating leases Operating Lease, Weighted Average Remaining Lease Term Intangible assets—developed technology Acquisitions Finite-lived Intangible Assets Acquired Schedule of disposal groups, including discontinued operations, income statement, balance sheet and additional disclosures Disposal Groups, Including Discontinued Operations [Table Text Block] Stock-based compensation expense Share-based Payment Arrangement, Expense Balance Sheet Location [Axis] Balance Sheet Location [Axis] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Disposal Group Name [Axis] Disposal Group Name [Axis] Impairments Impairment of Intangible Assets, Finite-lived Document Annual Report Document Annual Report Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Plans Other Than 2015 Plan Plans Other Than 2015 Plan [Member] Plans Other Than 2015 Plan [Member] 2015 Stock Incentive Plan Two Thousand Fifteen Stock Incentive Plan [Member] Two Thousand Fifteen Stock Incentive Plan [Member] 2024 Finance Lease, Liability, to be Paid, Year Four 2017 US generic pharmaceuticals restructuring US Generic Pharmaceuticals Restructuring 2017 [Member] US Generic Pharmaceuticals Restructuring 2017 [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] SAVINGS AND INVESTMENT PLAN AND DEFERRED COMPENSATION PLANS Savings And Investment Plan And Deferred Compensation Plans [Text Block] Savings And Investment Plan And Deferred Compensation Plans [Text Block] Contract assets, net - $ change Increase (Decrease) in Contract with Customer, Asset INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Schedule of Product Information [Table] Schedule of Product Information [Table] Cash paid out of Qualified Settlement Funds for mesh legal settlements Settlement Funds, Payments Settlement Funds, Payments Other Deferred Tax Liabilities, Other Lessee, operating lease, number of renewal options Lessee, Operating Lease, Number Of Renewal Options Lessee, Operating Lease, Number Of Renewal Options Summary of Income Tax Examinations Summary of Income Tax Examinations [Table Text Block] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Endo 401(k) Plan, Matching Tier Two Endo 401(k) Plan, Matching Tier Two [Member] Endo 401(k) Plan, Matching Tier Two [Member] Basis spread on variable rate, floor Debt Instrument Basis Spread on Variable Rate Floor Debt Instrument Basis Spread on Variable Rate Floor Extinguishment of debt, amount Extinguishment of Debt, Amount Accounts receivable Increase (Decrease) in Accounts Receivable Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] American Medical Systems American Medical Systems [Member] American Medical Systems [Member] Concentration Risk Type [Domain] Concentration Risk Type [Domain] TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT Liabilities and Equity Loss Contingencies [Line Items] Loss Contingencies [Line Items] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax INCOME TAXES Income Tax Disclosure [Text Block] Schedules of concentration of risk, by risk factor Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Decrease due to lapse of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Operating lease cost Operating Lease, Cost Deferred tax liabilities: Deferred Tax Liabilities, Gross [Abstract] Undistributed earnings of foreign subsidiaries Undistributed Earnings of Foreign Subsidiaries Certain other restructuring costs Other Restructuring Costs Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total current income tax Current Income Tax Expense (Benefit) Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Finance leases Finance Lease, Weighted Average Remaining Lease Term Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Gross additions for prior period positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Gross additions for current year positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Intangible life (years) Finite-Lived Intangible Asset, Useful Life Equity Component [Domain] Equity Component [Domain] Acquired in-process research and development charges Research and Development in Process Auxilium acquisition Auxilium Pharmaceuticals, Inc. [Member] Auxilium Pharmaceuticals, Inc. [Member] Gross profit Gross Profit Total property, plant and equipment, net Property, Plant and Equipment, Net Entity Tax Identification Number Entity Tax Identification Number Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] SHARE-BASED COMPENSATION Share-based Payment Arrangement [Text Block] NET INCOME (LOSS) NET INCOME (LOSS) Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Changes in assets and liabilities which (used) provided cash: Increase (Decrease) in Operating Capital [Abstract] Employee separation, continuity and other benefit-related costs and certain other restructuring costs Employee Separation, Continuity and Other Benefit-Related Costs And Other Restructuring Costs [Member] Employee Separation, Continuity and Other Benefit-Related Costs And Other Restructuring Costs London Interbank Offered Rate (LIBOR) London Interbank Offered Rate (LIBOR) [Member] INVENTORIES Inventory Disclosure [Text Block] Tradenames Trade Names [Member] Schedule Of Savings And Investment Plan And Deferred Compensation [Table] Schedule Of Savings And Investment Plan And Deferred Compensation [Table] Schedule Of Savings And Investment Plan And Deferred Compensation [Table] Schedule of intangible asset impairment charges including goodwill Schedule of Intangible Asset Impairment Charges Including Goodwill [Table Text Block] Schedule of Intangible Asset Impairment Charges Including Goodwill [Table Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Total finance lease liabilities Total finance lease liabilities Finance Lease, Liability Other SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment Number of cases filed by hospitals, health systems, unions, welfare funds or other third-party Loss Contingency, Number Of Cases Filed By Hospitals, Health Systems, Unions, Welfare Funds Or Other Third-Party Loss Contingency, Number Of Cases Filed By Hospitals, Health Systems, Unions, Welfare Funds Or Other Third-Party Vasostrict® Vasostrict [Member] Vasostrict [Member] Developed technology Developed Technology Rights [Member] Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Less: accumulated depreciation Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Other, net Other Nonrecurring (Income) Expense Financing activities Effective Income Tax Rate Reconciliation, Financing Activities, Amount Effective Income Tax Rate Reconciliation, Financing Activities, Amount Thereafter Finance Lease, Liability, to be Paid, after Year Five SUPPLEMENTAL INFORMATION: Supplemental Cash Flow Information [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Restructuring and related cost, cost incurred to date Restructuring and Related Cost, Cost Incurred to Date Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Effect of currency translation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) Schedule of property, plant and equipment Property, Plant and Equipment [Table Text Block] Other acquired assets Asset Acquisition, Other Noncurrent Assets Asset Acquisition, Other Noncurrent Assets Accelerated depreciation Accelerated Depreciation [Member] Accelerated Depreciation [Member] Fixed assets and intangible assets Deferred Tax Assets, Fixed and Intangible Assets Deferred Tax Assets, Fixed and Intangible Assets Credit facility, remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Ordinary shares issued (in shares) Stock Issued During Period, Shares, New Issues Gross Carrying Amount Beginning Balance Ending Balance Finite-Lived Intangible Assets, Gross Par Pharmaceutical, Inc. Par Pharmaceutical, Inc. [Member] Par Pharmaceutical, Inc. [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Restructuring and related cost, expected number of positions eliminated Restructuring and Related Cost, Expected Number of Positions Eliminated Money market funds Money Market Funds [Member] Contract with customer, asset, after allowance for credit loss, current Contract with Customer, Asset, after Allowance for Credit Loss, Current Vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Performance obligation satisfied in previous period Contract with Customer, Performance Obligation Satisfied in Previous Period Finance lease right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Luxembourg Luxembourg Inland Revenue [Member] Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Asset impairment charges Asset impairment charges Asset Impairment Charges [Member] Asset Impairment Charges [Member] Basic (in shares) For basic per share data—weighted average shares (in shares) Weighted average shares—Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Forfeited (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Restructuring reserve, current Restructuring Reserve, Current Loss Contingencies [Table] Loss Contingencies [Table] Plan Name [Domain] Plan Name [Domain] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer CONTRACT ASSETS AND LIABILITIES Revenue from Contract with Customer [Text Block] Operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Fair value of long term debt Long-term Debt, Fair Value Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Foreign currency loss (gain), net Foreign Currency Transaction Gain (Loss), before Tax Inventory Inventory, Policy [Policy Text Block] INCOME TAX (BENEFIT) EXPENSE INCOME TAX Income Tax Expense (Benefit) CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF PERIOD CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF PERIOD Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Schedule of maturities of long-term debt Schedule of Maturities of Long-term Debt [Table Text Block] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Current finance lease liabilities Finance Lease, Liability, Current Local Phone Number Local Phone Number Other nonrecurring (income) expense, expired insurance premium Other Nonrecurring (Income) Expense, Expired Insurance Premium Other Nonrecurring (Income) Expense, Expired Insurance Premium Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Tranche One Share-based Payment Arrangement, Tranche One [Member] Schedule of Goodwill And Other Intangibles [Table] Schedule of Goodwill And Other Intangibles [Table] Schedule of Goodwill and Other Intangibles [Table]. Options exercised intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Income tax benefit Discontinued Operation, Tax Effect of Discontinued Operation Changes to liability for acquisition-related contingent consideration Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Exercise price range, upper range limit (in dollars per share) Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Capitalized interest payments Interest Paid, Capitalized, Investing Activities Indefinite-lived intangibles: Indefinite-lived Intangible Assets [Roll Forward] Gross reductions for prior period positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Contract liabilities, net Contract with Customer, Liability SCHEDULE II--Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Exercise of options Stock Issued During Period, Value, Stock Options Exercised Cash distributions to settle disputes from Qualified Settlement Funds Loss Contingency Accrual, Payments To Plaintiff Counsel From Qualified Settlement Funds Loss Contingency Accrual, Payments To Plaintiff Counsel From Qualified Settlement Funds U.S. Internal Revenue Service (IRS) [Member] Award Type [Axis] Award Type [Axis] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Valuation Allowance [Line Items] Valuation Allowance [Line Items] Specialty Products Specialty Products [Member] Specialty Products [Member] Accumulated Deficit Retained Earnings [Member] Payments for contingent consideration Payment for Contingent Consideration Liability, Financing Activities Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Weighted Average Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Award Type [Domain] Award Type [Domain] Effect of Currency Translation Indefinite-lived Intangible Assets, Foreign Currency Translation Gain (Loss) Operating lease liabilities: Liabilities, Noncurrent [Abstract] Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Exercisable, end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Discontinued Operations and Disposal Groups [Abstract] Discontinued Operations and Disposal Groups [Abstract] PROPERTY, PLANT AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] Facility closing Facility Closing [Member] NET INCOME (LOSS) PER SHARE Earnings Per Share [Text Block] Established Products Established Products [Member] Established Products [Member] CURRENT LIABILITIES: Liabilities, Current [Abstract] Vested and expected to vest, end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Proceeds from draw of revolving debt Proceeds from Lines of Credit Discount rate Measurement Input, Discount Rate [Member] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] NET INCOME (LOSS) PER SHARE—BASIC: Earnings Per Share, Basic [Abstract]